Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Herceptin + Paclitaxel in HER2+ Metastatic Breast Cancer
NCT00005635Phase 2Completed
- Sponsor
- Genentech
- Start
- Jan 2000
- Primary completion
- Nov 2001
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by Genentech. Started Jan 2000; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00005635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005635.